We now understand that vitamin D is the starting material of an endocrine system primarily devoted to the regulation of serum calcium, serum phosphorus and bone. Vitamin D is normally produced in skin by a photochemical reaction of 7-dehydrocholesterol. It is subsequently converted in the liver to a circulating form (25-hydroxyvitamin D 3 ) that is then converted by the kidney to a hormonal form, 1a,25-dihydroxyvitamin D 3 . The vitamin D hormone acts through a single nuclear receptor in carrying out these functions. The presence of this receptor in a variety of tissues signals functions beyond bone, calcium and phosphorus. This presentation will provide the basic biology of the endocrine system, the current concepts of the molecular mechanisms by which it functions, and a look at the proven and putative functions of the hormone in the various target tissues. 
FGF23 is primarily produced in osteoblasts and osteocytes where it is secreted into the blood stream to act hormonally on specific target tissues. In the kidney, it has been shown to inhibit phosphate reabsorption and vitamin D synthesis by down-regulating the renal sodium phosphate co-transporters NaPi2a and NaPi2c and suppressing the expression of 1a(OH)ase in the proximal tubules. Mutations in the FGF23 gene itself or in genes regulating its expression and activation have been linked to disease processes including autosomal dominant hypophosphatemic rickets (ADHR), oncogenic osteomalacia (OOM) and X-linked hypophosphatemia (XLH), autosomal recessive hypophosphatemia with hyperphosphaturia (ARHR), confirming the role of FGF23 in regulating phosphate and vitamin D metabolism. A new role for FGF23 was discovered when Klotho, a previously described aging-related gene, was found to be a co-factor for FGF23 signaling. Apart from the kidney Klotho expression has also been detected in the parathyroid gland. More recent experiments have established a role for FGF23 in suppressing PTH transcription and secretion. These findings indicate that FGF23 can indirectly affect calcium homeostasis. Furthermore, the high levels of FGF23 found in patients with chronic kidney failure have been associated with increased risk of mortality and morbidity. FGF-23 has also been found to affect bone mineralization independent of its role in systemic phosphate homeostasis, adding significant new data regarding the physiological properties of FGF-23. Although the underlying mechanisms are still unclear, FGF23 appears to regulate the expression of various matrix mineralization inhibitors such as osteopontin, matrix Gla protein and dentin matrix protein. The novel findings that Klotho might also be expressed in bone cells strengthen the observation that FGF23 has paracrine action on bone. In summary, changes in FGF23 activity and the resulting effects on serum phosphate and calcium homeostasis have severe consequences on bone mineralization and ultimately on survival in mice and men. Hypovitaminosis D is not a new disease; however, in recent years there has been a resurgence of clinical disease within the US swine population. Clinical signs of re-emergence of this disease were first recognized in early 2010 and included lameness, posterior paresis, broken bones, muscle fasciculation/tremors, and sudden death. Morbidity of 50% and mortality in the range of 20% was common. The initial cases of hypovitaminosis D were connected to a particular feed manufacturer supplying a premix devoid of vitamin D which ultimately led to a national recall within five months of the first cases. This recall slowed the number of diagnostic cases and the attention associated with it motivated swine veterinarians and researchers to further investigate this issue. From 2010-present, the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) diagnosed over 100 cases. Case investigations typically involved determination of serum calcium, phosphorus, and vitamin D levels, assessment of bone quality, and microscopic evaluation of bones and joints. In many of these investigations the ISU VDL worked in collaboration with Heartland Labs in Ames, Iowa. These investigations generally led to the realization that large populations of pigs across the U.S. were either clinically or subclinically deficient in vitamin D. Clinical and diagnostic evidence continues to indicate that subclinical hypovitaminosis D as measured by serum vitamin D status is still occur-ring. Four companies have introduced oral products for supplementation of pigs, particular aimed at the weaned pig. Supplementation along with increased monitoring of bulk feed vitamin D samples, which have been shown to degrade with time, have reduced the incidence within the swine population. Speculations about alternative feed ingredients, calcium-phosphorus ratios, and even phytase usage have been made as a potential contributor to this recent rise in hypovitaminosis D in pigs. However, the primal underlying cause for these continued cases has not been elucidated at this time. Recent years have seen an increased interest in the extra-skeletal roles of vitamin D 3 . Pleiotropic effects on the immune system include those on monocyte, macrophage, neutrophil, B and T lymphocyte, and dendritic cell functions. The impacts to cellular immune mechanisms are relevant for host antimicrobial responses, inflammation, hematopoietic cell turnover and others. This presentation will discuss a recent study that examined the modulation of weanling pig cellular immunity in response to diet supplementation with 25-hydroxyvitamin D 3 [25(OH) D 3 ]. Analysis of functional traits showed that leukocyte cell numbers (P < 0.05) as well as proportions of individual granulocyte (P < 0.01) and lymphocyte subpopulations (P < 0.05) were significantly and differentially affected. There was also positive modulation of leukocyte survival across blood (P < 0.01) and bronchoalveolar (P < 0.05) compartments, highlighting the potential contributions to systemic and mucosal antimicrobial responses. This was consistent with a parallel upregulation in phagocytic functional responses in Hy-D supplemented pigs (P < 0.05). Importantly, challenges remain as we consider the mechanistic basis of these cellular changes. Recent approaches in cellular analysis provide novel alternatives for analysis, particularly in non-classical animal model systems where reagents such as leukocyte antibody-based markers are not as readily available. The extra-skeletal functions of vitamin D have gained greater attention in recent years. Emerging evidence that vitamin D and its metabolites are indeed involved in the proper development and growth of skeletal muscle in both mammalian and avian species will be the primary focus of this presentation. Recent work conducted in swine suggests that oral administration of 25-hydroxycholecalciferol (25OHD 3 ) in place of a majority of dietary vitamin D 3 improves both maternal and fetal vitamin D status as measured by circulating concentrations of 25OHD 3 . These improvements in vitamin D status resulted in enhancement of fetal skeletal muscle fiber number and alteration of fetal skeletal muscle satellite cell proliferation kinetics. These changes in fetal skeletal muscle developmental characteristics may result in improvements in the postnatal growth potential and ultimate red meat yield of these offspring. The cellular and molecular mechanisms by maternal supplementation and vitamin D status improvement augmented fetal development will require further effort. There is a growing body of commercial field research in which up to a 2% increase in breast meat yield has been observed when 25OHD 3 is included in broiler chicken diets. As is common in the broiler industry, replacement of the greater part of dietary vitamin D 3 with 25OHD 3 in caged-raised broilers resulted in a classic satellite cell-mediated muscle hypertrophy response in fast-twitch (pectoralis major) muscle. This conclusion is based on observation of increases in satellite cell density on d 14 and 21, nuclear density on d 28, and muscle fiber cross-sectional area at the conclusion of the study on d 49 in 25OHD 3 -fed birds. A mystery remains as to why a similar response was not observed in slow-twitch (biceps femoris) muscles also examined in the study. These findings shed light on the cellular mechanism behind the intriguing results obtained in field studies. Further investigation into the mechanisms by which vitamin D and its metabolites affect both pre-and postnatal development and growth of skeletal muscle is certainly warranted given the large number of questions that remain unanswered at this time. In sows 25-OH-D 3 plasma levels are cyclic, being highest in early gestation and lowest at weaning. In a five-parity study, Hy-D supplementation secured that 25-OH-D 3 plasma concentrations never dropped below the threshold to vitamin D insufficiency. The elevated 25-OH-D 3 levels during lactation resulted also in an increased plasma concentration of the active form 1,25-(OH) 2 -D 3 . Higher 25-OH-D 3 levels in milk were measured as well, which improved the vitamin D 3 status of the suckling piglets. In a growth trial 50 mcg 25-OH-D 3 /kg improved performance of growing pigs in comparison to a control group with 2000 IU vitamin D 3 /kg. Bone strength and bone mineralization were better with Hy-D both in the post-weaning and in the growing-finishing period. Optimum leg confirmation is of particular importance for the selection of gilts for breeding. When supplementing Hy-D during the full growth cycle, the selection rate of gilts was markedly improved under various production systems. Furthermore, the productivity of sows was ameliorated, related to piglets, born alive and litter weight at weaning. In conclusion, Hy-D is a versatile nutritional supplement, improving swine production at different levels. Even with safety margins of vitamin D (VD), Ca and P, over 8% of growing pigs may either be culled, or experience reduced growth due to structural unsoundness. Structural unsoundness is also a major cause for removal of breeding sows. Recently, the incidence of ostechondrosis (OC) lesions in sows was not linked to bone mineral concentrations. However, diets that provide excess Ca and P may increase mineral density of subchondral bone, possibly creating a rigidity stress on the cartilage preventing chondroblasts differentiation. A deficiency of VD may induce osteomalacia in adults, but bone mineralization in the offspring may also be affected. These responses may be mediated by P through FGF23. Thus, development of dietary inputs to regulate Ca and P homeostasis are necessary to sustain animal wellbeing. Traditional skeletal and extra-skeletal effects of VD are well accepted but an understanding of the non-classical responses within bone, such as effects on cartilage via cell differentiation may expand the practical applications for a role of VD in structural soundness. Epidemiological studies and empirical trials are needed to titrate VD requirements relative to structural soundness, but these trials are hampered by methods used to assess responses beyond those of bone mineralization. Assuming a greater absorption of 25OHVD than VD, our approach has used an assessment of a soundness scores to evaluate apparent OC in concert with measurements of Ca and P balance, particularly in lactating first litter gilts fed diets with varied VD, Ca and P concentrations. Growth performance and fibula ash validated the method of visual appraisal for structural soundness and gilts fed diets with 25OHVD had a greater number of femur osteoblast cells (P < 0.02). During lactation, at lower intakes, Ca and P retention were similar or improved (P < 0.01) by 25OHVD. Thus provision of greater dietary levels of VD from 25OHVD is a resource to sustain structural soundness of gilts and to protect efficiency of Ca and P use.
Key
D has significant roles in extraskeletal health. Too little or too much vitamin D can lead to poor performance and death. Access to reliable analytical
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